The pharmaceutical company announced that the US drug regulator has concluded its inspection at the new injectable facility in Andhra Pradesh, with three observations.
Subscribe To Our Free Newsletter |
The pharmaceutical company announced that the US drug regulator has concluded its inspection at the new injectable facility in Andhra Pradesh, with three observations.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!